Coya Therapeutics (COYA) Other Operating Expenses (2022 - 2026)

Coya Therapeutics (COYA) has 5 years of Other Operating Expenses data on file, last reported at -$1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 3.76% year-over-year to -$1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$3.2 million (up 28.1% YoY), and the FY2025 full-year result was -$3.2 million, up 29.17% from the prior year.
• Other Operating Expenses retreated to -$1.3 million in Q1 2026, from $295912.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $396840.0 in Q4 2022 to a low of -$1.5 million in Q2 2025.
• A 5-year average of -$467252.6 and a median of $4033.0 in 2022 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses jumped 8748.0% in 2023 and tumbled 21512.0% in 2024, its largest moves.
• Tracing COYA's Other Operating Expenses over 5 years: stood at $396840.0 in 2022, then tumbled by 49.6% to $200026.0 in 2023, then sank by 592.49% to -$985101.0 in 2024, then surged by 130.04% to $295912.0 in 2025, then plunged by 531.76% to -$1.3 million in 2026.
• Business Quant data shows COYA's Other Operating Expenses at -$1.3 million in Q1 2026, $295912.0 in Q4 2025, and -$659157.0 in Q3 2025.